| 0 |
AORTIC THROMBOSIS |
1 |
0.0009 |
| 1 |
APPLICATION SITE INFLAMMATION |
1 |
0.0007 |
| 2 |
SKIN EROSION |
2 |
0.0006 |
| 3 |
MEAN CELL HAEMOGLOBIN INCREASED |
1 |
0.0006 |
| 4 |
BLOOD CHOLESTEROL DECREASED |
1 |
0.0005 |
| 5 |
EYELID IRRITATION |
1 |
0.0004 |
| 6 |
BLOOD SODIUM INCREASED |
1 |
0.0004 |
| 7 |
CANDIDIASIS |
1 |
0.0002 |
| 8 |
SPINAL FUSION SURGERY |
1 |
0.0002 |
| 9 |
AORTIC DISSECTION |
1 |
0.0002 |
| 10 |
BLEPHAROSPASM |
1 |
0.0002 |
| 11 |
ONYCHOCLASIS |
1 |
0.0001 |
| 12 |
HAIR GROWTH ABNORMAL |
1 |
0.0001 |
| 13 |
LOW DENSITY LIPOPROTEIN INCREASED |
1 |
0.0001 |
| 14 |
VITAMIN D DECREASED |
1 |
0.0001 |
| 15 |
BLOOD MAGNESIUM DECREASED |
1 |
0.0001 |
| 16 |
CONJUNCTIVITIS |
2 |
0.0001 |
| 17 |
APPENDICITIS |
1 |
0.0001 |
| 18 |
SLEEP APNOEA SYNDROME |
2 |
0.0001 |
| 19 |
VITAMIN D DEFICIENCY |
1 |
0.0001 |
| 20 |
HYPERLIPIDAEMIA |
1 |
0.0001 |
| 21 |
CORONARY ARTERY OCCLUSION |
1 |
0.0001 |
| 22 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
1 |
0.0001 |
| 23 |
SCAR |
1 |
0.0001 |
| 24 |
BLOOD TRIGLYCERIDES INCREASED |
1 |
0.0001 |
| 25 |
SKIN FISSURES |
1 |
0.0001 |
| 26 |
HAEMATOCRIT DECREASED |
1 |
0.0001 |
| 27 |
INJECTION SITE WARMTH |
1 |
0.0000 |
| 28 |
SKIN EXFOLIATION |
4 |
0.0000 |
| 29 |
FIBROMYALGIA |
1 |
0.0000 |
| 30 |
ECZEMA |
2 |
0.0000 |
| 31 |
DERMATITIS ATOPIC |
2 |
0.0000 |
| 32 |
BLOOD BILIRUBIN INCREASED |
1 |
0.0000 |
| 33 |
SKIN LESION |
1 |
0.0000 |
| 34 |
RED BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 35 |
THERAPEUTIC RESPONSE DECREASED |
2 |
0.0000 |
| 36 |
CARDIAC DISORDER |
3 |
0.0000 |
| 37 |
NIGHT SWEATS |
1 |
0.0000 |
| 38 |
CARDIO-RESPIRATORY ARREST |
1 |
0.0000 |
| 39 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
1 |
0.0000 |
| 40 |
SKIN IRRITATION |
1 |
0.0000 |
| 41 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 42 |
HERPES ZOSTER |
1 |
0.0000 |
| 43 |
PALPITATIONS |
2 |
0.0000 |
| 44 |
SWELLING FACE |
1 |
0.0000 |
| 45 |
BURNING SENSATION |
1 |
0.0000 |
| 46 |
SLEEP DISORDER |
1 |
0.0000 |
| 47 |
SKIN BURNING SENSATION |
1 |
0.0000 |
| 48 |
RASH |
6 |
0.0000 |
| 49 |
ACNE |
1 |
0.0000 |
| 50 |
CONDITION AGGRAVATED |
4 |
0.0000 |
| 51 |
DIABETES MELLITUS |
1 |
0.0000 |
| 52 |
PRURITUS |
5 |
0.0000 |
| 53 |
INJECTION SITE BRUISING |
1 |
0.0000 |
| 54 |
INJECTION SITE HAEMORRHAGE |
1 |
0.0000 |
| 55 |
CARDIAC FAILURE CONGESTIVE |
1 |
0.0000 |
| 56 |
GASTROOESOPHAGEAL REFLUX DISEASE |
1 |
0.0000 |
| 57 |
GASTROINTESTINAL DISORDER |
1 |
0.0000 |
| 58 |
FLUSHING |
1 |
0.0000 |
| 59 |
HAEMOGLOBIN DECREASED |
1 |
0.0000 |
| 60 |
ERYTHEMA |
2 |
0.0000 |
| 61 |
PLATELET COUNT DECREASED |
1 |
0.0000 |
| 62 |
INFLUENZA |
1 |
0.0000 |
| 63 |
MEMORY IMPAIRMENT |
1 |
0.0000 |
| 64 |
WEIGHT DECREASED |
2 |
0.0000 |
| 65 |
PERIPHERAL SWELLING |
1 |
0.0000 |
| 66 |
PARAESTHESIA |
1 |
0.0000 |
| 67 |
SOMNOLENCE |
1 |
0.0000 |
| 68 |
HYPERTENSION |
1 |
0.0000 |
| 69 |
WEIGHT INCREASED |
1 |
0.0000 |
| 70 |
DEPRESSION |
1 |
0.0000 |
| 71 |
PRODUCT USE IN UNAPPROVED INDICATION |
1 |
0.0000 |
| 72 |
INJECTION SITE PAIN |
1 |
0.0000 |
| 73 |
DYSPNOEA |
1 |
0.0000 |
| 74 |
HEADACHE |
1 |
0.0000 |
| 75 |
NAUSEA |
1 |
0.0000 |